Skip to Main Content

Paper Details

Cost of Exempting Sole Orphan Drugs From Medicare Negotiation.
JAMA Intern Med
1
2024
Author NameAffiliation
Aaron S KesselheimDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Aaron S KesselheimHarvard Medical School
  • 1 - 2

Datasets

Release 1.2